AU2006233207A1 - Hepatitis C virus inhibitors - Google Patents
Hepatitis C virus inhibitorsInfo
- Publication number
- AU2006233207A1 AU2006233207A1 AU2006233207A AU2006233207A AU2006233207A1 AU 2006233207 A1 AU2006233207 A1 AU 2006233207A1 AU 2006233207 A AU2006233207 A AU 2006233207A AU 2006233207 A AU2006233207 A AU 2006233207A AU 2006233207 A1 AU2006233207 A1 AU 2006233207A1
- Authority
- AU
- Australia
- Prior art keywords
- hepatitis
- virus inhibitors
- virus
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2006233207A AU2006233207B2 (en) | 2002-05-20 | 2006-10-26 | Hepatitis C virus inhibitors |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/382,055 | 2002-05-20 | ||
AU2003241510A AU2003241510B2 (en) | 2002-05-20 | 2003-05-20 | Hepatitis C virus inhibitors |
AU2006233207A AU2006233207B2 (en) | 2002-05-20 | 2006-10-26 | Hepatitis C virus inhibitors |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003241510A Division AU2003241510B2 (en) | 2002-05-20 | 2003-05-20 | Hepatitis C virus inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2006233207A1 true AU2006233207A1 (en) | 2006-11-16 |
AU2006233207B2 AU2006233207B2 (en) | 2009-07-30 |
Family
ID=37461310
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2006233207A Ceased AU2006233207B2 (en) | 2002-05-20 | 2006-10-26 | Hepatitis C virus inhibitors |
AU2006233208A Ceased AU2006233208B2 (en) | 2002-05-20 | 2006-10-26 | Hepatitis C virus inhibitors |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2006233208A Ceased AU2006233208B2 (en) | 2002-05-20 | 2006-10-26 | Hepatitis C virus inhibitors |
Country Status (1)
Country | Link |
---|---|
AU (2) | AU2006233207B2 (en) |
-
2006
- 2006-10-26 AU AU2006233207A patent/AU2006233207B2/en not_active Ceased
- 2006-10-26 AU AU2006233208A patent/AU2006233208B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU2006233207B2 (en) | 2009-07-30 |
AU2006233208A1 (en) | 2006-11-16 |
AU2006233208B2 (en) | 2009-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1070287A1 (en) | Hepatitis c virus inhibitors | |
EP1684787A4 (en) | Hepatitis c virus inhibitors | |
EP1684745A4 (en) | Hepatitis c virus inhibitors | |
AU2003259155A1 (en) | Pharmaceutical compositions comprising hepatitis c viral protease inhibitors | |
AU2003202263A1 (en) | Roh-kinase inhibitors | |
AU2003261434A1 (en) | Iminothiazolidinones as inhibitors of hcv replication | |
AU2003215806A1 (en) | Disinfectant with activity against hepatitis b virus | |
AU2003206862A1 (en) | Hepatitis b vaccines | |
AU2003249683A1 (en) | Nf-:b inhibitors | |
AU2003229474A1 (en) | Methods and compositions for detecting sars virus | |
AU2003294757A1 (en) | Formulations useful against hepatitis c virus infections | |
AU2002257890A1 (en) | Method for replicating the hepatitis C virus | |
AU2003301865A1 (en) | Epitopes of hepatitis c virus | |
AU2003255727A1 (en) | Syringes | |
AU2003269185A1 (en) | Software protection | |
AU2003256404A1 (en) | Hepatitis c virus assays | |
AU2003251356A1 (en) | Viral marker | |
AU2003230790A1 (en) | Hepatitis c virus sub-genomic replicons | |
AU2003266243A1 (en) | 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors | |
AU2003289016A1 (en) | Method of distinguishing drug-resistance of hepatitis b virus | |
AU2003237701A1 (en) | Vaccines | |
AU2003225479A1 (en) | Reporter-selectable hepatitis c virus replicon | |
AU2006233207A1 (en) | Hepatitis C virus inhibitors | |
AU2003234047A1 (en) | Magnetrons | |
AU2003214299A1 (en) | Hiv-1 virus tat-protein mutants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) | ||
PC | Assignment registered |
Owner name: BRISTOL-MYERS SQUIBB HOLDINGS IRELAND Free format text: FORMER OWNER WAS: BRISTOL-MYERS SQUIBB COMPANY |
|
NC | Extension of term for standard patent requested (sect. 70) |
Free format text: PRODUCT NAME: SUNVEPRA ASUNAPREVIR Filing date: 20150525 |
|
NDA | Extension of term for standard patent accepted (sect.70) |
Free format text: PRODUCT NAME: SUNVEPRA ASUNAPREVIR Filing date: 20150525 |
|
NDB | Extension of term for standard patent granted (sect.76) |
Free format text: PRODUCT NAME: SUNVEPRA ASUNAPREVIR Filing date: 20150525 Extension date: 20280520 |
|
HB | Alteration of name in register |
Owner name: BRISTOL-MYERS SQUIBB HOLDINGS IRELAND UNLIMITED CO Free format text: FORMER NAME(S): BRISTOL-MYERS SQUIBB HOLDINGS IRELAND |
|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |